Register Login

Abiopharma

  • Home
  • About
  • Newsroom
  • Company List
  • Events
  • Automated Tools
  • Contact

News list

GLAXOSMITHKLINE CONS

  • FDA Approval
  • Nov. 30, 2023, 09:45 UTC
  • 43
  • 0 comments

FDA approve DICLOFENAC SODIUM

Comment Full text

SANDOZ

  • FDA Approval
  • Nov. 30, 2023, 09:45 UTC
  • 41
  • 0 comments

FDA approve LEVETIRACETAM

Comment Full text

ALKEM LABS LTD

  • FDA Approval
  • Nov. 29, 2023, 09:37 UTC
  • 41
  • 0 comments

FDA approve BREXPIPRAZOLE

Comment Full text

NOVAST LABS

  • FDA Approval
  • Nov. 29, 2023, 09:37 UTC
  • 41
  • 0 comments

FDA approve TRIAZOLAM

Comment Full text

JIANGSU HANSOH PHARM

  • FDA Approval
  • Nov. 29, 2023, 09:37 UTC
  • 35
  • 0 comments

FDA approve ICATIBANT ACETATE

Comment Full text

WOCKHARDT BIO AG

  • FDA Approval
  • Nov. 29, 2023, 09:37 UTC
  • 39
  • 0 comments

FDA approve ABIRATERONE ACETATE

Comment Full text

SANDOZ INC

  • FDA Approval
  • Nov. 29, 2023, 09:37 UTC
  • 39
  • 0 comments

FDA approve FLUVASTATIN SODIUM

Comment Full text

THERAVIA

  • FDA Approval
  • Nov. 29, 2023, 09:37 UTC
  • 40
  • 0 comments

FDA approve HYDROXYUREA

Comment Full text

SANDOZ

  • FDA Approval
  • Nov. 29, 2023, 09:37 UTC
  • 37
  • 0 comments

FDA approve OXALIPLATIN

Comment Full text

AAIPHARMA LLC

  • FDA Approval
  • Nov. 29, 2023, 09:37 UTC
  • 40
  • 0 comments

FDA approve AZATHIOPRINE

Comment Full text
  • Previous
  • 627
  • 628
  • 629
  • 630
  • 631
  • Next

Search

News categories

  • Technical Exchange News(13176)
  • Event(6229)
  • SEC News(330915)
  • FDA Approval(10304)
  • Company Report(721)
  • Business News(184791)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin